Resultados de búsqueda - Kim‐Anh Do
- Mostrando 1 - 20 Resultados de 69
- Ir a la Siguiente Página
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Phase III Trial of Androgen Ablation With or Without Three Cycles of Systemic Chemotherapy for Advanced Prostate Cancer por Randall E. Millikan, Sijin Wen, Lance C. Pagliaro, Melissa A. Brown, Brenda Moomey, Kim‐Anh Do, Christopher J. Logothetis
Publicado 2008Artigo -
8
ST8SIA1 Regulates Tumor Growth and Metastasis in TNBC by Activating the FAK–AKT–mTOR Signaling Pathway por Khoa Nguyen, Yuanqing Yan, Bin Yuan, Abhishek Dasgupta, Jeffrey Sun, Hong Mu, Kim‐Anh Do, Naoto T. Ueno, Michael Andreeff, V. Lokesh Battula
Publicado 2018Artigo -
9
Longitudinal study of smoking patterns in relation to the development of smoking‐related secondary primary tumors in patients with upper aerodigestive tract malignancies por Kim‐Anh Do, Marcella M. Johnson, J. Jack Lee, Xi Feng Wu, Qiong Dong, Waun Ki Hong, Fadlo R. Khuri, Margaret R. Spitz
Publicado 2004Artigo -
10
-
11
-
12
Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer por Funda Meric‐Bernstam, Huiqin Chen, Argun Akçakanat, Kim‐Anh Do, Aña Lluch, Bryan T. Hennessy, Gabriel N. Hortobágyi, Gordon B. Mills, Ana M. González-Angulo
Publicado 2012Artigo -
13
Morphologic Characterization of Preoperatively Treated Prostate Cancer: Toward a Post-Therapy Histologic Classification por Eleni Efstathiou, Neil A. Abrahams, Rita F. Tibbs, Xuemei Wang, Curtis A. Pettaway, Louis L. Pisters, Paul Mathew, Kim‐Anh Do, Christopher J. Logothetis, Patricia Troncoso
Publicado 2009Artigo -
14
-
15
Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia por Constantine S. Tam, Susan O’Brien, William G. Wierda, Hagop M. Kantarjian, Sijin Wen, Kim‐Anh Do, Deborah A. Thomas, Jorge E. Cortés, Susan Lerner, Michael J. Keating
Publicado 2008Artigo -
16
Gene Expression, Molecular Class Changes, and Pathway Analysis after Neoadjuvant Systemic Therapy for Breast Cancer por Ana M. González-Angulo, Takayuki Iwamoto, Shuying Liu, Huiqin Chen, Kim‐Anh Do, Gabriel N. Hortobágyi, Gordon B. Mills, Funda Meric‐Bernstam, W. Fraser Symmans, Lajos Pusztai
Publicado 2012Artigo -
17
High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients por Ashley M. Holder, Ana M. González-Angulo, Huiqin Chen, Argun Akçakanat, Kim‐Anh Do, W. Fraser Symmans, Lajos Pusztai, Gabriel N. Hortobágyi, Gordon B. Mills, Funda Meric‐Bernstam
Publicado 2012Artigo -
18
Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significance por Taghi Manshouri, Kim‐Anh Do, Xuemei Wang, Francis J. Giles, Susan O’Brien, Helen Saffer, Deborah A. Thomas, Iman Jilani, Hagop M. Kantarjian, Michael J. Keating, Maher Albitar
Publicado 2003Artigo -
19
Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone por Apostolia M. Tsimberidou, Daniel Catovsky, Ellen Schlette, Susan O’Brien, William G. Wierda, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Sijin Wen, Kim‐Anh Do, Susan Lerner, Michael J. Keating
Publicado 2006Artigo -
20
Biomarkers of Response to Akt Inhibitor MK-2206 in Breast Cancer por Takafumi Sangai, Argun Akçakanat, Huiqin Chen, Emily Tarco, Yun Wu, Kim‐Anh Do, Todd W. Miller, Carlos L. Arteaga, Gordon B. Mills, Ana M. González-Angulo, Funda Meric‐Bernstam
Publicado 2012Artigo
Herramientas de búsqueda:
Materias Relacionadas
Medicine
Internal medicine
Biology
Cancer
Oncology
Cancer research
Genetics
Biochemistry
Gene
Breast cancer
Gastroenterology
Leukemia
Chronic lymphocytic leukemia
Immunology
Prostate cancer
Chemistry
Chemotherapy
Surgery
Cell biology
PI3K/AKT/mTOR pathway
Pathology
Protein kinase B
Signal transduction
Computational biology
Lymphoma
Proportional hazards model
Bioinformatics
Metastasis
Microbiome
Paleontology